Literature DB >> 20426903

Is nasopharyngeal cancer really a "Cantonese cancer"?

Joseph Tien Seng Wee1, Tam Cam Ha, Susan Li Er Loong, Chao-Nan Qian.   

Abstract

Nasopharyngeal cancer (NPC) is endemic in Southern China, with Guandong province and Hong Kong reporting some of the highest incidences in the world. The journal Science has called it a "Cantonese cancer". We propose that in fact NPC is a cancer that originated in the Bai Yue ("proto Tai Kadai" or "proto Austronesian" or "proto Zhuang") peoples and was transmitted to the Han Chinese in southern China through intermarriage. However, the work by John Ho raised the profile of NPC, and because of the high incidence of NPC in Hong Kong and Guangzhou, NPC became known as a Cantonese cancer. We searched historical articles, articles cited in PubMed, Google, monographs, books and Internet articles relating to genetics of the peoples with high populations of NPC. The migration history of these various peoples was extensively researched, and where possible, their genetic fingerprint identified to corroborate with historical accounts. Genetic and anthropological evidence suggest there are a lot of similarities between the Bai Yue and the aboriginal peoples of Borneo and Northeast India; between Inuit of Greenland, Austronesian Mayalo Polynesians of Southeast Asia and Polynesians of Oceania, suggesting some common ancestry. Genetic studies also suggest the present Cantonese, Minnans and Hakkas are probably an admixture of northern Han and southern Bai Yue. All these populations have a high incidence of NPC. Very early contact between southern Chinese and peoples of East Africa and Arabia can also account for the intermediate incidence of NPC in these regions.

Entities:  

Mesh:

Year:  2010        PMID: 20426903     DOI: 10.5732/cjc.009.10329

Source DB:  PubMed          Journal:  Chin J Cancer        ISSN: 1944-446X


  98 in total

1.  Overexpression of asparagine synthetase and matrix metalloproteinase 19 confers cisplatin sensitivity in nasopharyngeal carcinoma cells.

Authors:  Ran-Yi Liu; Zizheng Dong; Jianguo Liu; Ling Zhou; Wenlin Huang; Sok Kean Khoo; Zhongfa Zhang; David Petillo; Bin Tean Teh; Chao-Nan Qian; Jian-Ting Zhang
Journal:  Mol Cancer Ther       Date:  2013-08-16       Impact factor: 6.261

2.  Value of contrast-enhanced MRI in the differentiation between nasopharyngeal lymphoid hyperplasia and T1 stage nasopharyngeal carcinoma.

Authors:  Ming-Liang Wang; Xiao-Er Wei; Meng-Meng Yu; Wen-Bin Li
Journal:  Radiol Med       Date:  2017-06-24       Impact factor: 3.469

Review 3.  Basic consideration of research strategies for head and neck cancer.

Authors:  Jin Gao; Ben Panizza; Newell W Johnson; Scott Coman; Alan R Clough
Journal:  Front Med       Date:  2012-09-28       Impact factor: 4.592

4.  Monoacylglycerol lipase promotes metastases in nasopharyngeal carcinoma.

Authors:  Wen-Rong Hu; Yi-Fan Lian; Li-Xia Peng; Jin-Ju Lei; Cheng-Cheng Deng; Miao Xu; Qi-Sheng Feng; Li-Zhen Chen; Jin-Xin Bei; Yi-Xin Zeng
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo.

Authors:  Xiaowei Peng; Peiguo Cao; Jingjing Li; Dong He; Shuang Han; Jianda Zhou; Guolin Tan; Wei Li; Fenghui Yu; Jianjun Yu; Zan Li; Ke Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

6.  The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients.

Authors:  Rou Jiang; Xiong Zou; Wen Hu; Yu-Ying Fan; Yue Yan; Meng-Xia Zhang; Rui You; Rui Sun; Dong-Hua Luo; Qiu-Yan Chen; Pei-Yu Huang; Yi-Jun Hua; Ling Guo; Ming-Yuan Chen
Journal:  Tumour Biol       Date:  2015-05-06

7.  Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Authors:  Huai Liu; Pei-Yu Huang; Lin-Quan Tang; Qiu-Yan Chen; Ying Zhang; Lu Zhang; Ling Guo; Dong-Hua Luo; Hao-Yuan Mo; Yan-Qun Xiang; Fang Qiu; Rui Sun; Ming-Yuan Chen; Yi-Jun Hua; Xing Lv; Lin Wang; Chong Zhao; Xiang Guo; Ka-Jia Cao; Chao-Nan Qian; Ming-Huang Hong; Hai-Qiang Mai
Journal:  Med Oncol       Date:  2013-08-18       Impact factor: 3.064

8.  Tumor microenvironment macrophage inhibitory factor directs the accumulation of interleukin-17-producing tumor-infiltrating lymphocytes and predicts favorable survival in nasopharyngeal carcinoma patients.

Authors:  Jiang Li; Hao-Yuan Mo; Geng Xiong; Lin Zhang; Jia He; Zhou-Feng Huang; Zhi-Wei Liu; Qiu-Yan Chen; Zi-Ming Du; Li-Min Zheng; Chao-Nan Qian; Yi-Xin Zeng
Journal:  J Biol Chem       Date:  2012-08-14       Impact factor: 5.157

9.  Overexpression of osteopontin promotes cell proliferation and migration in human nasopharyngeal carcinoma and is associated with poor prognosis.

Authors:  Haimei Qin; Rong Wang; Guijiang Wei; Huaifei Wang; Guogang Pan; Rentong Hu; Yesheng Wei; Renguang Tang; Junli Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-06       Impact factor: 2.503

10.  Exploration of the postponing mechanism that delays carcinoma onset.

Authors:  Chao-Nan Qian
Journal:  Cancer Cell Int       Date:  2010-10-22       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.